Ulcerative colitis with acute pleurisy: A case report and review of the literature.
|Abstract||Inflammatory bowel diseases (IBD), including ulcerative colitis (UC) and Crohn's disease, are associated with a large number of extraintestinal manifestations. Pulmonary manifestations are infrequently seen in patients with IBD. Moreover, serositis including pleural and pericardial manifestations in UC is rare.|
Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
|Publication Year Start||2017-01-01|
PMID- 28746225 OWN - NLM STAT- MEDLINE DA - 20170726 DCOM- 20170807 LR - 20170807 IS - 1536-5964 (Electronic) IS - 0025-7974 (Linking) VI - 96 IP - 30 DP - 2017 Jul TI - Ulcerative colitis with acute pleurisy: A case report and review of the literature. PG - e7630 LID - 10.1097/MD.0000000000007630 [doi] AB - RATIONALE: Inflammatory bowel diseases (IBD), including ulcerative colitis (UC) and Crohn's disease, are associated with a large number of extraintestinal manifestations. Pulmonary manifestations are infrequently seen in patients with IBD. Moreover, serositis including pleural and pericardial manifestations in UC is rare. PATIENT CONCERNS: We report a case of UC with acute pleurisy in a 43-year-old man; review literature; and discuss the diagnosis, differential diagnosis, and treatment. DIAGNOSES: Active duodenal ulcer was found using gastroscopy. Multiple ulcers in segmented pattern were noticed in the left hemi-colon using colonoscopy. An UC in active stage was confirmed subsequently by histology. INTERVENTION: The patient was treated with bifidobacterium tetravaccine tablets, oral mesalazine and mesalazine enemas. The omeprazole and mucosal protective agents were given to treat the duodenal ulcer. OUTCOMES: As follow-up, the therapy including oral mesalazine and infliximab regularly was continued and the patient condition was stabilized. MAIN LESSON: Pulmonary involvement should be considered in patients who develop pleurisy in UC. Infliximab is considered the better available treatment for patients presenting with pleurisy in UC. FAU - Lu, Shuming AU - Lu S AD - aDepartment of Gastroenterology, First Affiliated Hospital of Dalian Medical University, Dalian bDepartment of Medical Imaging, Qingdao Women and Children's Hospital, Qingdao, China cDepartment of Radiology, First Affiliated Hospital of Dalian Medical University dDepartment of Pathology, Dalian Municipal Central Hospital, Dalian, China. FAU - Wang, Lihua AU - Wang L FAU - Zhang, Weisheng AU - Zhang W FAU - Zhang, Zhuqing AU - Zhang Z FAU - Liu, Lina AU - Liu L FAU - Wang, Yingde AU - Wang Y FAU - Meng, Hua AU - Meng H LA - eng PT - Case Reports PT - Journal Article PT - Review PL - United States TA - Medicine (Baltimore) JT - Medicine JID - 2985248R SB - AIM SB - IM MH - Adult MH - Colitis, Ulcerative/*complications/*diagnosis/therapy MH - Diagnosis, Differential MH - Humans MH - Male MH - Pleurisy/*complications/*diagnosis/therapy EDAT- 2017/07/27 06:00 MHDA- 2017/08/08 06:00 CRDT- 2017/07/27 06:00 AID - 10.1097/MD.0000000000007630 [doi] AID - 00005792-201707280-00056 [pii] PST - ppublish SO - Medicine (Baltimore). 2017 Jul;96(30):e7630. doi: 10.1097/MD.0000000000007630.